col0,col1,col2,col3,col4
PTEN EXPRESSION,trastuzumab,PTEN,human chromosome 10,Fulvestrant / everolimus combination therapy
TP53 DELETERIOUS MUTATION,adjuvant therapy,TP53,human chromosome 17,ro-5045337
DNMT1 EXPRESSION,decitabine,DNMT1,human chromosome 19,cisplatin
TP53 OVEREXPRESSION,etoposide / mitomycin / cisplatin combination therapy,TP53,human chromosome 17,cisplatin
CCND1 OVEREXPRESSION,palbociclib,CCND1,human chromosome 11,tamoxifen
CD274 EXPRESSION,nivolumab,CD274,human chromosome 9,radiation therapy
chr9:g.133748414T>A (ABL1:p.F359I),dasatinib,ABL1,human chromosome 9,imatinib
ABL1 Y393C,dasatinib,ABL1,human chromosome 9,imatinib
ABL1 Y342H,dasatinib,ABL1,human chromosome 9,imatinib
ABL1 V289I,dasatinib,ABL1,human chromosome 9,imatinib
KIT W557_K558DELWK,imatinib,KIT,human chromosome 4,imatinib
ZEB1 EXPRESSION,Salinomycin / doxorubicin combination therapy,ZEB1,human chromosome 10,doxorubicin
ERBB3 OVEREXPRESSION,afatinib / selumetinib combination therapy,ERBB3,human chromosome 12,cetuximab
NRG1 EXPRESSION,cisplatin,NRG1,human chromosome 8,cetuximab
chr9:g.133748289T>G (ABL1:p.F317C),nilotinib,ABL1,human chromosome 9,dasatinib
chr9:g.133748288T>A (ABL1:p.F317I),nilotinib,ABL1,human chromosome 9,dasatinib
chr9:g.133748288T>G (ABL1:p.F317V),nilotinib,ABL1,human chromosome 9,dasatinib
chr9:g.133748282A>G (ABL1:p.T315A),nilotinib,ABL1,human chromosome 9,dasatinib
CDK6 OVEREXPRESSION,Fulvestrant / palbociclib combination therapy,CDK6,human chromosome 7,Fulvestrant
AREG EXPRESSION,Panitumumab,AREG,human chromosome 4,crizotinib
